Navigation Links
Rensselaer professors Dordick and Interrante named ACS Fellows
Date:10/4/2010

Troy, N.Y. Two Rensselaer Polytechnic Institute professors have been named 2010 fellows of the American Chemical Society (ACS). Director of the Center for Biotechnology and Interdisciplinary Studies (CBIS) and the Howard P. Isermann '42 Professor of Chemical and Biological Engineering Jonathan Dordick and Professor Emeritus of Chemistry Leonard Interrante were both recognized by the ACS for their "outstanding achievements in and contributions to the science, the profession, and service to the society."

"Both of these esteemed researchers and educators have had a major impact on their fields," said Rensselaer Provost Robert Palazzo. "Dr. Dordick is among the foremost biocatalysis and bioengineering experts in the world. His recent discovery of antibacterial coatings could protect thousands of people from harmful bacterial infections and his work to develop biochip technologies is transforming the way we view the modern drug discovery process.

"Dr. Interrante is both a polymer pioneer and successful entrepreneur. He has developed sophisticated new materials utilized in technologies around the world, including the Hubble Space Telescope. His pure silicon carbide-forming polymer is the only of its kind commercially available in the world, paving the way for an entirely new generation of high-temperature, high-strength ceramic composites."

The ACS honored the new fellows at the society's fall national meeting.

Dordick's research interests are in the areas of biocatalysis, bioengineering, and nanobiotechnology. He most recently developed a nanoscale coating for surgical equipment, hospital walls, and other surfaces that safely eradicates methicillin-resistant Staphylococcus aureus (MRSA). He has also discovered a biochip that could eliminate animal testing in the chemicals and cosmetics industries, and drastically curtail its use in the development of new pharmaceuticals. The co-founder of EnzyMed Inc., a pharmaceutical discovery company, he is c
'/>"/>

Contact: Gabrielle DeMarco
demarg@rpi.edu
518-956-0701
Rensselaer Polytechnic Institute
Source:Eurekalert

Page: 1 2

Related biology news :

1. Trustee makes donation to start new solar energy research center at Rensselaer
2. Rensselaer receives more than $2 million from New York State to fund stem cell research
3. Rensselaer leads effort to replace 1 of the most widely used drugs in American hospitals
4. Rensselaer researchers to send bacteria into orbit aboard space shuttle Atlantis
5. Rensselaer Polytechnic Institute wins $2.45 million grant to support stem cell research
6. Rensselaer Polytechnic Institute professor Patrick Underhill receives NSF CAREER award
7. Rensselaer Polytechnic Institute professor Peter M. Tessier named Pew Scholar
8. Left or right? Early clues to soccer penalty kicks revealed at Rensselaer Polytechnic Institute
9. Rensselaer professor uncovers mysterious workings of cholera bacteria
10. Purifying proteins: Rensselaer researchers use NMR to improve drug development
11. National Science Foundation grants Clemson professors award to develop nanoprobes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2014)... study has revealed that nicotine and cotinine, a metabolite ... a certain carcinogen in smoke. , The carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone ... leaves and ultimately ends up in the tobacco smoke. ... liver, where it is activated by a variety of ... has revealed that nicotine can partially interfere with the ...
(Date:7/27/2014)... the southern Western Ghats, a mountain range along the west ... that any mayfly belonging to the genus Labiobaetis ... called Labiobaetis soldani , "is named in honor of ... of the Ephemeroptera of Palaearctic and Oriental realms," according to ... in the Journal of Insect Science . , The ...
(Date:7/27/2014)... at Barts Cancer Institute have found that targeting a ... more effective, according to research published in Nature ... part of Queen Mary University of London, have found ... the body to repair itself after chemotherapy or radiotherapy, ... researchers removed FAK from blood vessels that grew in ...
Breaking Biology News(10 mins):Nicotine found to inhibit DNA-strand break caused by a certain carcinogen in smoke 2New drug target can break down cancer's barrier against treatment 2
... antibacterial medicine that kills the superbug MRSA is being ... Trust. The Seeding Drug Discovery initiative is aimed at ... unmet need. , Prolysis, an R&D company based ... Drug Discovery awards for its new antibacterial compounds aimed ...
... discovery in stem cell research may mean big things for ... a research team at the University of Kentucky published their ... , The researchers genetically mapped a stem cell gene and ... the investigation all the way through to the identification of ...
... as SORL1 may be a factor in the development of ... discovered. The genetic clue, which could lead to a better ... Genetics online, Jan. 14, 2007, and was supported in part ... researchers suggest that faulty versions of the SORL1 gene contribute ...
Cached Biology News:New antibacterials being developed to tackle MRSA superbug 2Researchers first to map gene that regulates adult stem cell growth 2Scientists find new genetic clue to cause of Alzheimer's disease 2
(Date:7/28/2014)... --  Propeller Health , the FDA-cleared digital health solution ... Brad Towle as Senior Vice President, Business and ... company,s sales growth, customer acquisition and program expansion. ... past role in the development of accountable care organizations, ... time in the industry," said David Van Sickle ...
(Date:7/28/2014)... 28, 2014 It’s a hard truth: Nearly ... to further their post-secondary education are failing to obtain a ... this year. And according to an analysis by The ... veteran students’ uninformed choice of college majors, which leads to ... the study: Some 51.7 percent of post-9/11 veterans using ...
(Date:7/28/2014)... Calif. , July 28, 2014  InterMune, Inc. ... will release its second quarter 2014 financial results at ... 6, 2014. A live conference call and webcast will be ... same day. Interested investors and others may ... or +1 212-231-2900 (international), conference ID#21728775. A replay of the ...
(Date:7/28/2014)... Research and Markets has announced the addition of ... to their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... to determine the size of a particle in a material ... the size of particles as it can affect the functionality ... determine the behavior and nature of a material, and for ...
Breaking Biology Technology:Propeller Health Hires Brad Towle as Senior Vice President of Business and Client Development 2Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 2Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 3Resume Place: To Choose the Best College Majors, Veterans Need Early Career Counseling, Data Shows 4InterMune to Release Second Quarter Financial Results on August 6 2Global Particle Size Analysis Market 2014-2018 2
... from McGill,s Physics Department and Mike Lilly from Sandia ... electronic circuits. It is formed by two wires separated ... This discovery, published in the journal Nature Nanotechnology ... and power of the ever smaller integrated circuits of ...
... LONDON, December 7, 2011 Silence Therapeutics plc ... ( RNAi ) therapeutics company, announces a positive outcome from the ... (EPO) over opposition to Silence,s granted European Patent EP 1 536 ... The granted patent refers to the gene target PKN3, protein ...
... 2011  PDL BioPharma, Inc. (PDL) (NASDAQ: PDLI ) ... , 2.875% Convertible Senior Notes due February 15, 2015 ... $1,000 principal amount or approximately $6.44 per share, effective December ... May 1, 2015 (May 2015 Notes) is 135.9849 shares of ...
Cached Biology Technology:Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office 2Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office 3Silence Therapeutics Announces Positive Outcome From Oral Hearing at the European Patent Office 4PDL BioPharma Announces Adjusted Conversion Rates for Its Convertible Notes 2
5-bromo-4-chloro-3-indolyl b -D-galactopyranoside (X-Gal)...
... Attoglow Western Blot Analysis Kit is ... kit developed by Biochain. It detects ... g) or yoctomole (10 -24 ... three parts: Millennium Enhancer, protein interaction ...
... BioNumerics is the universal bioinformatics software that ... data. The unique modular design of BioNumerics ... virtually any type of data employed for ... microarrays, DNA fingerprints, 2-D protein gels, HPLC, ...
... the early 80s Biosearch Technologies has ... oligonucleotide tools to accelerate the discovery ... you need dual-labeled FRET probes and ... oligos for microarray applications, Biosearch can ...
Biology Products: